STOCK TITAN

Sol-Gel Technologies (SLGL) COO discloses stock option positions in Form 3

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Sol-Gel Technologies Ltd. executive Yosef Itzik, the Chief Operating Officer, reported his initial beneficial ownership of stock options on Ordinary Shares. He holds options over 2,031 Ordinary Shares at an exercise price of 100.0000 per share, expiring on March 29, 2032.

He also holds options over 566 Ordinary Shares at an exercise price of 56.0000 per share, expiring on March 9, 2033, and 499 Ordinary Shares at an exercise price of 8.9600 per share, expiring on February 18, 2035. The footnotes describe vesting schedules where 25% of each grant vests on a specified initial date, with the remaining portion vesting in equal quarterly installments, subject to his continued service.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Yosef Itzik

(Last)(First)(Middle)
C/O SOL-GEL TECHNOLOGIES LTD.
7 GOLDA MEIR STREET

(Street)
NESS ZIONA7403650

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026
3. Issuer Name and Ticker or Trading Symbol
Sol-Gel Technologies Ltd. [ SLGL ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Operating Officer
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy) (2)03/29/2032Ordinary Shares(1)2,031$100D
Stock Option (right to buy) (3)03/09/2033Ordinary Shares(1)566$56D
Stock Option (right to buy) (4)02/18/2035Ordinary Shares(1)499$8.96D
Explanation of Responses:
1. Ordinary shares, NIS 1.00 par value per share
2. The option vested as to 25% of the Ordinary Shares on March 29, 2023 and vests as to the remainder of the Ordinary Shares in equal quarterly installments over the following three years, subject to the Reporting Person's continued service through such dates.
3. The option vests as to 25% of the Ordinary Shares on June 9, 2026 and vests as to the remainder of the Ordinary Shares in equal quarterly installments over the following nine months, subject to the Reporting Person's continued service through such dates.
4. The option vested as to 25% of the Ordinary Shares on February 18, 2026 and vests as to the remainder of the Ordinary Shares in equal quarterly installments over the following three years, subject to the Reporting Person's continued service through such dates.
Remarks:
Exhibit 24 - Power of Attorney
/s/Eyal Ben-Or, Attorney-in-Fact03/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Sol-Gel Technologies (SLGL) COO Yosef Itzik report in this Form 3?

The filing shows COO Yosef Itzik’s initial beneficial ownership of stock options on Sol-Gel Technologies’ Ordinary Shares. It details three option positions, including exercise prices, expiration dates, and vesting schedules tied to his continued service with the company.

How many Sol-Gel Technologies (SLGL) shares are covered by Yosef Itzik’s stock options?

The options cover 2,031, 566, and 499 Ordinary Shares in three separate grants. Each grant represents the number of underlying Sol-Gel Technologies shares that can potentially be acquired if the options are fully vested and exercised under their terms.

What are the exercise prices of the Sol-Gel (SLGL) stock options held by Yosef Itzik?

The reported stock options have exercise prices of 100.0000, 56.0000, and 8.9600 per Ordinary Share. These prices are the amounts per share that must be paid to acquire the underlying Sol-Gel Technologies Ordinary Shares upon exercising the options.

When do Yosef Itzik’s Sol-Gel Technologies (SLGL) stock options expire?

The options expire on March 29, 2032, March 9, 2033, and February 18, 2035, respectively. These expiration dates set the last day each option can be exercised to purchase the underlying Sol-Gel Ordinary Shares, assuming vesting and other conditions are satisfied.

How do the Sol-Gel (SLGL) stock options for COO Yosef Itzik vest?

Each option grant vests 25% on an initial date, with the remaining shares vesting in equal quarterly installments. Vesting is conditioned on Yosef Itzik’s continued service with Sol-Gel Technologies through the applicable vesting dates, as described in the footnotes.

Does this Sol-Gel Technologies (SLGL) Form 3 show any share purchases or sales by Yosef Itzik?

The Form 3 lists holdings of stock options but no purchases or sales of Ordinary Shares. Transaction summaries show no buy or sell activity, only option positions and their terms as part of the initial ownership disclosure by the executive.
Sol Gel Technolg

NASDAQ:SLGL

View SLGL Stock Overview

SLGL Rankings

SLGL Latest News

SLGL Latest SEC Filings

SLGL Stock Data

227.63M
835.67k
Biotechnology
Healthcare
Link
Israel
Ness Ziona